Advertisement
Screener

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Defined Benefit Plan, Amortization of Gain (Loss)

1.6 / 5 stars · 37/115 Roast Me

INTEGRA LIFESCIENCES HOLDINGS CORP Defined Benefit Plan, Amortization of Gain (Loss)

INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Defined Benefit Plan, Amortization of Gain (Loss) of -$1.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses · last filed 2026-02-26

  • INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, amortization of gain (loss) for the quarter ending 2010-12-31 was $26.00K.
  • INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, amortization of gain (loss) for the quarter ending 2010-09-30 was -$38.00K.
  • INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, amortization of gain (loss) for the quarter ending 2010-06-30 was -$36.00K.
  • INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, amortization of gain (loss) for fiscal 2025 was -$1.00K.
  • INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, amortization of gain (loss) for fiscal 2024 was -$6.00K, a 101.53% decline from fiscal 2023.
  • INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, amortization of gain (loss) for fiscal 2023 was $391.00K.
  • INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, amortization of gain (loss) for fiscal 2022 was -$9.00K.
Period endDefined Benefit Plan, Amortization of Gain (Loss) 3 monthDefined Benefit Plan, Amortization of Gain (Loss) 6 monthDefined Benefit Plan, Amortization of Gain (Loss) 9 monthDefined Benefit Plan, Amortization of Gain (Loss) 12 month
2025-12-31-$1.00K
10-K · filed 2026-02-26
2024-12-31-$6.00K
10-K · filed 2026-02-26
2023-12-31$391.00K
10-K · filed 2026-02-26
2022-12-31-$9.00K
10-K · filed 2024-02-28
2021-12-31-$186.00K
10-K · filed 2023-02-22
2020-12-31-$787.00K
10-K · filed 2022-02-24
2019-12-31-$65.00K
10-K · filed 2021-02-23
2018-12-31-$8.00K
10-K · filed 2020-02-21
2017-12-31-$8.00K
10-K · filed 2019-02-26
2014-12-31-$53.00K
10-K · filed 2015-02-27
2013-12-31-$2.00K
10-K · filed 2015-02-27
2012-12-31$0.00
10-K · filed 2015-02-27
2011-12-31$0.00
8-K · filed 2014-06-20
2010-12-31$26.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
-$12.00K
derived: sum of 2 quarters · filed 2013-02-26
-$48.00K
derived: sum of 3 quarters · filed 2013-02-26
-$86.00K
10-K · filed 2013-02-26
2010-09-30-$38.00K
10-Q · filed 2011-10-31
-$74.00K
derived: sum of 2 quarters · filed 2011-10-31
-$112.00K
10-Q · filed 2011-10-31
2010-06-30-$36.00K
10-Q · filed 2011-08-01
-$74.00K
10-Q · filed 2011-08-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92